22NW, LP
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), 22NW, LP reported 16 stock positions worth $158.5 million. Its top holding was Foster (lb) Class A (FSTR) at 22.3% of the portfolio, followed by Lifecore Biomedical (LFCR, 19.6%) and Anebulo Pharmaceuticals (ANEB, 16.4%). Compared with Q3 2024, it opened 4 new positions, sold out of 1 and added to 2. The biggest buy was Anebulo Pharmaceuticals (ANEB, shares +188%) and the biggest sale an exit from Psychemedics (PMDI).
- Most Recent 13F
- Q2 2026
- Location
- SEATTLE, WA
- CIK
- 0001694297
- Portfolio Value
- $158.5M (Q4 2024)
- SEC Filing
- 0001214659-25-002859 ↗ filed Feb 14, 2025
Holdings Value
Holdings 16 stocks · $158.5M
| FSTR Foster (lb) Co. Class A | 22.28% | 1,313,121 | $35.3M | No change |
| LFCR Lifecore Biomedical Inc. | 19.65% | 1,755,161 | $31.1M | No change |
| ANEB Anebulo Pharmaceuticals Inc. | 16.39% | 15,467,300 | $26.0M | Add +188.2% |
| STRL Sterling Infrastructure Inc. | 10.60% | 99,783 | $16.8M | No change |
| BBSI Barrett Business SVCS Inc. | 7.26% | 264,904 | $11.5M | No change |
| CULP Culp Inc. | 6.02% | 1,624,715 | $9.5M | Add +1.9% |
| PFX Phenixfin Corp. | 3.74% | 117,885 | $5.9M | No change |
| DHX Dhi Group Inc. | 2.91% | 2,603,643 | $4.6M | No change |
| FARM Farmer Bros Co. | 2.22% | 1,955,526 | $3.5M | No change |
| MTW Manitowoc Company Inc. | 2.05% | 356,115 | $3.3M | No change |
| LNTH Lantheus Holdings Inc. | 1.95% | 34,562 | $3.1M | No change |
| SRI Stoneridge Inc. | 1.36% | 342,787 | $2.1M | New |
| NKTR Nektar Therapeutics | 1.29% | 2,191,750 | $2.0M | New |
| SSKN Strata Skin Sciences Inc. | 0.98% | 536,995 | $1.6M | No change |
| UFI Unifi Inc. | 0.92% | 233,777 | $1.5M | New |
| PMDI Psychemedics Corp. | 0.39% | 276,034 | $618K | New |
Portfolio Sells Q3 2024 → Q4 2024
| PMDI Psychemedics Corp. | Sold out | 0.00% | −0.53 |
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $104.7M | NSP, NKTR, SRI, FOXF, CMT |
| Q1 2026 | 16 | $145.9M | FSTR, NKTR, LFCR, NSP, MLYS |
| Q4 2025 | 20 | $237.6M | ANEB, FSTR, LFCR, NKTR, RGNX |
| Q3 2025 | 21 | $212.3M | ANEB, FSTR, LFCR, NKTR, SRI |
| Q2 2025 | 21 | $158.8M | FSTR, LFCR, ANEB, SRI, DHX |
| Q1 2025 | 20 | $149.1M | LFCR, FSTR, ANEB, STRL, CULP |
| Q4 2024 | 16 | $158.5M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q3 2024 | 13 | $119.3M | FSTR, LFCR, STRL, CULP, ANEB |
| Q2 2024 | 13 | $117.2M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q1 2024 | 13 | $116.1M | FSTR, ANEB, STRL, LFCR, BBSI |